Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1569 ARTÍCULOS , VIENDO DEL 1051 AL 1065

Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer's Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study

Hong YJ, Choi SH, Jeong JH, Park KW, Na HR.

J Alzheimers Dis. 2018;63(3):1035-1044. doi: 10.3233/JAD-180159.

Exercise Intervention Associated with Cognitive Improvement in Alzheimer's Disease

Cui MY, Lin Y, Sheng JY, Zhang X, Cui RJ.

Neural Plast. 2018 Mar 11;2018:9234105. doi: 10.1155/2018/9234105. eCollection 2018.

Issues in Geriatric Care: Alzheimer Disease

Kemle K, Ackermann RJ.

FP Essent. 2018 May;468:26-34.

A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study

Ridha BH, Crutch S, Cutler D, Frost C, Knight W, Barker S, Epie N, Warrington EK, Kukkastenvehmas R, Douglas J, Rossor MN.

Alzheimers Res Ther. 2018 May 1;10(1):44. doi: 10.1186/s13195-018-0363-1.

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease

Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Sur C, Mukai Y, Voss T, Furtek C, Mahoney E, Harper Mozley L, Vandenberghe R, Mo Y, Michelson D.

N Engl J Med. 2018 May 3;378(18):1691-1703. doi: 10.1056/NEJMoa1706441.

Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement

Wattmo C, Londos E, Minthon L.

Curr Alzheimer Res. 2018;15(10):905-916. doi: 10.2174/1567205015666180507105326.

Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region

Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Hamano N, Li SD, Chougule M, Shoyele SA, Gupta U, Ajazuddin, Alexander A.

Expert Opin Drug Deliv. 2018 Jun;15(6):589-617. doi: 10.1080/17425247.2018.1471058. Epub 2018 May 17.

The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease

Jazvinšćak Jembrek M, Slade N, Hof PR, Šimić G.

Prog Neurobiol. 2018 Sep;168:104-127. doi: 10.1016/j.pneurobio.2018.05.001. Epub 2018 May 4.

Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimer's Disease

Goyal D, Kaur A, Goyal B.

ChemMedChem. 2018 Jul 6;13(13):1275-1299. doi: 10.1002/cmdc.201800156. Epub 2018 Jun 19.

Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study

Wang GH, Wang LH, Wang C, Qin LH.

Medicine (Baltimore). 2018 May;97(19):e0636. doi: 10.1097/MD.0000000000010636.

The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer's Disease

Kazmierski J, Messini-Zachou C, Gkioka M, Tsolaki M.

Am J Alzheimers Dis Other Demen. 2018 Sep;33(6):385-393. doi: 10.1177/1533317518775044. Epub 2018 May 9.

Passive Aβ Immunotherapy: Current Achievements and Future Perspectives

Schilling S, Rahfeld JU, Lues I, Lemere CA.

Molecules. 2018 May 3;23(5):1068. doi: 10.3390/molecules23051068.

Network Medicine for Alzheimer's Disease and Traditional Chinese Medicine

Jarrell JT, Gao L, Cohen DS, Huang X.

Molecules. 2018 May 11;23(5):1143. doi: 10.3390/molecules23051143.

Alzheimer's Disease, Dendritic Spines, and Calcineurin Inhibitors: A New Approach?

O'Neal MA, Stallings NR, Malter JS.

ACS Chem Neurosci. 2018 Jun 20;9(6):1233-1234. doi: 10.1021/acschemneuro.8b00213. Epub 2018 May 14.

Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies

Quinn JF.

J Alzheimers Dis. 2018;64(s1):S33-S39. doi: 10.3233/JAD-179930.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias